European Journal of Drug Metabolism and Pharmacokinetics to be published by Springer

New acquisition reinforces pharmacology and drug research portfolios

Starting in 2010, Springer will publish the European Journal of Drug Metabolism and Pharmacokinetics. All aspects of drug delivery and bioavailability are covered in the journal, which was previously published by the Swiss publisher M-decine & Hygi-ne. The journal was founded in 1975 by the late Professor Achille Benakis at the University of Geneva, Switzerland, and through the years gathered a loyal community of authors and readers. focuses on aspects such as pharmacokinetics, drug metabolism, drug interactions and all aspects of drug development. The journal provides relevant information from this research area, publishing original articles, short preliminary communications, review articles on special topics and conference proceedings. Published four times a year, the journal is indexed in Medline and Current Contents.

The European Journal of Drug Metabolism and Pharmacokinetics

"We started working with Professor Benakis just weeks before he passed away," said Guido Zosimo-Landolfo, Managing Director of Springer France. "The journal's move to Springer is one of his last decisions. We are keen to improve the journal's influence and impact through our multidisciplinary publishing program and our broad distribution network."

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Spermidine regulates RIPK1 to combat diabetes and vascular damage